Lasa Supergenerics Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

2.13

EPS

—

Div Yield, %

—

Shrs. gr., 5y

4.27%

Rev. gr., 5y

-34.11%

Revenues

251m

-82.35%

Net income

-341m

L+131.00%

CFO

-81m

L+185.70%

Dividend

Sep 16, 20220.25 INR/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Lasa Supergenerics Limited, founded in 2016 and based in Mumbai, India, specializes in the development, manufacturing, and commercialization of various healthcare products for both human and animal well-being. Its operations predominantly cater to the Indian domestic market, though the firm also distributes its offerings internationally. The company's product portfolio includes active pharmaceutical ingredients (APIs) for veterinary applications and other uses, as well as anthelmintic drugs, ingredients for animal feed, and specialized reagents employed in therapeutic treatments.

URL

https://lasalabs.com/

IPO date

Sep 21, 2017

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title INR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title INR in thousands, except ratios and share amounts	2026‑03	2025‑03	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT